MedPath

The effect of cupping method in the treatment of menorrhagia

Phase 3
Conditions
DUB.
Excessive, frequent and irregular menstruation
Registration Number
IRCT2016052528080N1
Lead Sponsor
Tehran university of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
162
Inclusion Criteria

women with uterine bleeding disorders; Patients referred by a gynecologist with disorders of uterine bleeding; patient with completed informed consent form
Exclusion criteria: women younger than 20 or older than 50 years; history of chest surgery in the last three months; active systemic infection disease; active infected edema on Skin or injury on cupping site; coagulation disorders; use of bleeding-lowering drugs such as Mefenamic acid, etc. during the study period; uterine fibrosis with endometrial thickness; fraction in the chest area ,especially in the ribs 7-12 on cupping site; chemical medicines or herbal and other alternative medicine methods used during the study; pregnant or plan to become pregnant during the study; dependence on drugs in the past 6 months

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Patient’s score of bleeding. Timepoint: the first menstrual cycle as well as one and three months after the intervention. Method of measurement: Pictorial Assessment of Blood Loss questionnaire.
Secondary Outcome Measures
NameTimeMethod
Menorrhagia quality of life questionnaire. Timepoint: 1 month. Method of measurement: questionnaire.
© Copyright 2025. All Rights Reserved by MedPath